EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Progress toward new function and design of extracellular G protein-coupled receptor nanobodies

Roman R Schlimgen, Brian F Volkman

Molecular Pharmacology · 2025-08 · 107 (8) · 100054

DOI: 10.1016/j.molpha.2025.100054 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Pharmacology, 2025-08. Verfasst von Roman R Schlimgen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Receptors, G-Protein-Coupled, Drug Design. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibodies have played a pivotal role in G protein-coupled receptor (GPCR) research and drug development. Nanobodies, or variable domain heavy chain-only antibodies, have emerged as a next-generation antibody with unique advantages in targeting GPCRs. The first generation of intracellular nanobodies have been instrumental in stabilizing GPCR structures for crystallography and in enabling in vitro GPCR imaging. More recently, extracellular-targeted nanobodies have demonstrated diverse pharmacological profiles, with the ability to modulate GPCR activity, localization, and downstream signaling. With these newly uncovered functional properties, nanobodies can be viewed not only as structural tools but also as modulators of receptor pharmacology. We highlight recent innovations in extracellular GPCR-targeting nanobodies and assess several approaches to accelerate their development as versatile research tools and therapeutics. SIGNIFICANCE STATEMENT: Nanobodies have emerged as a next-generation antibody platform with distinct advantages for targeting G protein-coupled receptors. This review highlights recent advances in extracellular G protein-coupled receptor-targeting nanobodies and explores innovative strategies to accelerate their development as powerful research tools and therapeutic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesReceptors, G-Protein-CoupledDrug DesignHumansAnimalsSignal TransductionExtracellular Space

Stichwörter der Autor:innen

ExtracellularG protein–coupled receptorNanobodySingle domain antibodiesVariable domain heavy chain–only antibodies

Substanzen

Single-Domain AntibodiesReceptors, G-Protein-Coupled

Autor:innen und Institutionen

  • Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin; Program in Chemical Biology, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for Immunology, Medical College of Wisconsin, Milwa…

Förderung

  • NIAID NIH HHS
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Schlimgen, R. R., & Volkman, B. F. (2025). Progress toward new function and design of extracellular G protein-coupled receptor nanobodies. Molecular Pharmacology, 107(8), 100054. https://doi.org/10.1016/j.molpha.2025.100054

Vancouver

Schlimgen RR, Volkman BF. Progress toward new function and design of extracellular G protein-coupled receptor nanobodies. Molecular Pharmacology. 2025;107(8):100054. doi:10.1016/j.molpha.2025.100054

BibTeX
@article{Schlimgen2025,
  author = {Schlimgen, Roman R and Volkman, Brian F},
  title = {Progress toward new function and design of extracellular G protein-coupled receptor nanobodies},
  journal = {Molecular Pharmacology},
  year = {2025},
  volume = {107},
  number = {8},
  pages = {100054},
  doi = {10.1016/j.molpha.2025.100054}
}
Kostenlos starten →